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Abstract Objective: To evaluate
the association between arterial blood
pressure (ABP) during the first 24 h
and mortality in sepsis.
Design: Retrospective cohort study.
Setting: Multidisciplinary intensive
care unit (ICU). Patients and partic-
ipants: A total of 274 septic
patients. Interventions: None. Mea-
surements and
results: Hemodynamic, and labora-
tory parameters were extracted from a
PDMS database. The hourly time
integral of ABP drops below clini-
cally relevant systolic arterial
pressure (SAP), mean arterial pres-
sure (MAP), and mean perfusion
pressure (MPP = MAP - central
venous pressure) levels was calcu-
lated for the first 24 h after ICU
admission and compared with 28-
day-mortality. Binary and linear
regression models (adjusted for SAPS
II as a measure of disease severity),
and a receiver operating characteristic
(ROC) analysis were applied. The
areas under the ROC curve were
largest for the hourly time integrals of
ABP drops below MAP 60 mmHg
(0.779 vs. 0.764 for ABP drops below
MAP 55 mmHg; P B 0.01) and MPP
45 mmHg. No association between
the hourly time integrals of ABP
drops below certain SAP levels and
mortality was detected. One or more
episodes of MAP \ 60 mmHg
increased the risk of death by 2.96 (CI
95%, 1.06–10.36, P = 0.04). The area
under the ROC curve to predict the
need for renal replacement therapy
was highest for the hourly time inte-
gral of ABP drops below
MAP 75 mmHg. Conclusions: A
MAP level C 60 mmHg may be as
safe as higher MAP levels during the
first 24 h of ICU therapy in septic
patients. A higher MAP may be
required to maintain kidney function.
Keywords Hypotension 
Mean arterial blood pressure 
Mean perfusion pressure  Sepsis
Introduction
Cardiovascular failure is a major determinant of outcome
[1–3]. Arterial blood pressure (ABP) is widely used to
monitor and guide hemodynamic therapy. Although
numerous studies have evaluated different strategies to
increase ABP [4, 5], few data exist to which level ABP
should be elevated. In septic shock, mean arterial blood
pressure (MAP) targets between 65–90 mmHg have been
proposed [6–8]. The ABP levels achieved in various
studies appear to be remarkably higher, e.g. 80–95 mmHg
[9, 10], than those specified in the respective protocols.
Determination of a clinically relevant ABP target could
influence the extent of pharmacological support in
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critically ill sepsis patients. So far, only two small pro-
spective studies including a total of 38 patients evaluated
tissue perfusion at different ABPs [11, 12].
A retrospective study by Varpula et al. [13] addressed
hemodynamic treatment goals in 111 septic shock
patients. The association between the area below thresh-
old values of specific cardiovascular variables during the
first 48 h of septic shock and 30-day-mortality was
assessed, without adjustment for disease severity. The
area below a MAP of 65 mmHg and a mixed venous
oxygen saturation of 70% was most predictive of 30-day-
mortality.
Since ABP targets in septic shock remain controver-
sial, we evaluated the association between different ABP
levels during the first 24 h after ICU admission and 28-
day-mortality and organ function in 274 sepsis patients
using a disease severity adjusted model. We hypothesized
that lower ABPs than commonly targeted may be well-
tolerated. Parts of this work were presented as an abstract
at the twentieth Congress of the European Society of
Intensive Care Medicine [14].
Patients and methods
This retrospective, explorative cohort study was per-
formed in a 30-bed multi-disciplinary ICU in a university
hospital. All medical records from 1 January 2005 until
30 June 2006 were reviewed for patients admitted to the
ICU because of sepsis defined according to the American
College of Chest Physicians and the Society of Critical
Care Medicine [15]. Patients \ 18 years, discharged alive
\24 h after ICU admission, or developed sepsis during
their ICU stay were excluded. The study protocol was
approved by the Ethic Committee of the Canton Bern.
All study variables were extracted from the institu-
tional patient data management system database
(Centricity Critical Care Clinisoft; Deio, Kuopio, Fin-
land). Routine data recording includes demographic and
clinical patient characteristics. Hemodynamic parameters
are prospectively recorded. The system uses median fil-
tering which is an effective non-linear, digital filtering
process to eliminate artefacts from a signal. Thus, single
ABP values over 2 min are summarized as a median value
[16]. All laboratory results are automatically imported
into the system. Drugs and fluids administered are man-
ually entered into the database at the bedside.
Hemodynamic therapy
An arterial, a central venous and a pulmonary artery
catheter was in place in 274 (100%), 227 (82.8%), and 74
(27%) patients, respectively. Hemodynamic therapy of
study patients was based on an institutional protocol
which served as a treatment guideline (Electronic
Repository). According to this, all patients received
repetitive fluid challenges based on the response of ABP,
heart rate, central venous pressure, mixed venous oxygen
saturation, and the adequacy of peripheral circulation. If
signs of tissue hypoperfusion (lactic acidosis, signs of
peripheral vasoconstriction) persisted and catecholamines
were required, a pulmonary artery catheter (Swan Ganz
CCOmbo CCO/SvO2/VIP; Edwards Lifesciences Inc.,
Irvine, CA, USA) with continuous cardiac output mea-
surement (Vigilance; Edwards Lifesciences Inc., Irvine,
CA, USA) was inserted. In these patients, fluid loading
was guided according to changes of stroke volume index
and mixed venous oxygen saturation in response to vol-
ume infusion (predominantly colloids). If mixed venous
oxygen saturation remained \60% despite optimal fluid
resuscitation and acceptable hemoglobin, inotropic ther-
apy with dobutamine (second line agent, epinephrine) was
initiated. If MAP remained \55–60 mmHg despite the
use of volume and inotropes, norepinephrine was instal-
led. Individual MAP targets were set between 50 and
75 mmHg according to urine output, arterial lactate lev-
els, adequacy of peripheral circulation, and mixed venous
oxygen saturation.
Study variables
Demographic data, pre-existent diseases, source of
infection and in case of surgery incidence and type of
operation were documented. Septic shock was defined as
the presence of sepsis together with persistent arterial
hypotension which could not be explained by other causes
and required the infusion of inotropic and/or vasopressor
agents [14]. SAPS II [17] and Acute Physiology and
Chronic Health Evaluation (APACHE) II [18] were cal-
culated from worst clinical parameters during the first
24 h after admission. Length of ICU and hospital stay, and
patient outcome at ICU discharge were recorded. Twenty-
eight day mortality was calculated from ICU records, the
hospital database, or in case of transfer to external insti-
tutions before day 28 by contacting these hospitals.
Hemodynamic data documentation
Manual quality and plausibility control of individual
datasets was performed to exclude artefacts (e.g. due to
blood sampling via the arterial line). We have previously
demonstrated that clinicians can efficiently detect arte-
facts in monitored trends [19]. Mean hemodynamic
values during the first 24 h after ICU admission were
calculated. Mean perfusion pressure (MPP = MAP -
central venous pressure) and in patients with a pulmonary
artery catheter, systemic vascular resistance index was
calculated.
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For systolic arterial blood pressure (SAP), MAP, and
MPP the blood pressure time integral of the measured
ABP curve during the first 24 h was calculated (Elec-
tronic Repository). Because of differences in the actual
recorded ABP time due to diagnostic and/or operative
procedures, the integral was normalized for the time
recorded (hourly integral) for each variable was intro-
duced into the statistical model. In case of death within
24 h, hemodynamic variables during the last 30 min
before cardiac arrest and variables recorded after the
decision to withdraw life-sustaining therapy were exclu-
ded. The hourly time integral of ABP drops below certain
threshold levels of SAP (95, 90, 85, 80, 75, 70,
65 mmHg), MAP (75, 70, 65, 60, 55, 50, 45 mmHg) and
MPP (60, 55, 50, 45, 40, 35, 30 mmHg) was calculated.
Wherever possible, individually prescribed MAP targets
were recorded (Electronic Repository) and the hourly
time integral of ABP drops below this target was calcu-
lated. Application of cardiovascular active drugs,
analgosedative medications, and diuretics during the
observation period was documented in a binary fashion.
Laboratory data documentation
The most aberrant standard laboratory parameters during
the ICU stay were extracted from the database. Hourly
urine output during the first 24 h and need for renal
replacement therapy (decisions to start renal replacement
therapy for acute renal failure were made together with a
nephrologist) were recorded. The Sequential Organ Fail-
ure Assessment (SOFA) score [20] was calculated daily
from given clinical and laboratory parameters. Organ
failure was defined as greater than three points in each
organ subscore of SOFA.
Study endpoints
The primary endpoint was to evaluate the SAP, MAP and
MPP levels during the first 24 h after ICU admission
which were associated best with 28-day-mortality. The
secondary endpoint was to evaluate the association
between ABPs during the first 24 h after ICU admission
and organ function.
Statistical analysis
All statistical analyses were performed with the SPSS
12.0.1. (SPSS, Chicago, IL, USA) and STATA software
9.2. (StataCorp, College Station, TX, USA). Kolmogo-
rov–Smirnov tests were used to check for normality
distribution. In case of non-normal distribution, logarith-
mic transformation was used. As appropriate, unpaired
student’s t and v2 tests were used to compare data
between survivors and nonsurvivors and other subgroups,
respectively.
A binary logistic regression model was used to eval-
uate the association between the hourly blood pressure
time integral of measured ABPs as well as the hourly time
integral of ABP drops below certain ABP levels and 28-
day-mortality or organ failures. To account for disease
severity, the SAPS II (excluding SAP count) was entered
into the models as a covariate. The area under the receiver
operator characteristic (ROC) curve, sensitivity, speci-
ficity, and negative and positive predictive values was
determined from the final classification tables of the
logistic regression models. The ABP level below which
the hourly time integral of ABP drops showed the largest
area under the ROC curve was considered to have the best
association with 28-day-mortality and was subsequently
compared with other ABP levels in the same group (SAP,
MAP, MPP) using an algorithm suggested by DeLong
et al. [21].
For continuous variables (e.g. maximum laboratory
values), a linear regression model including SAPS II
(excluding SAP count) as a covariate was applied.
Patients with chronic renal insufficiency (elevated base-
line creatinine concentration) and patients receiving
diuretics during the observation period were excluded
from the regression analyses evaluating the association
between ABP and creatinine serum concentrations and
urine output/h, respectively. Patients on chronic hemodi-
alysis were excluded from the model for the assessment of
the association between ABP and need for renal
replacement therapy. In order to exclude collinearity, age,
the hourly cardiac index time integral, chronic arterial
hypertension (documented history and/or repeatedly
measured increased values according to WHO limits
before the septic episode), need for catecholamines and
analgosedative drugs were entered as covariates into
single logistic regression models.
For simple comparisons, P values \ 0.05 were con-
sidered to indicate statistical significance. In case of
multiple comparisons, P values \ 0.007 (regression
analyses evaluating the association between seven ABP
levels and 28-day-mortality as well as organ function)
were applied. Data are given as mean values ± SD, if not
indicated otherwise.
Results
During the observation period, 4,590 patients were
admitted to the ICU. A total of 274 patients fulfilled the
inclusion criteria and were included in the analysis
(Table 1). SAP and MAP were recorded for 21.6 ± 3.6 h,
MPP for 18.9 ± 5.2 h (Electronic Repository). Seven
study patients died during the 24 h observation period.
Patients with septic shock had a higher ICU—(25.7 vs.
1227
11.9%; P = 0.006) and 28-day-mortality (37.2 vs. 16.7%;
P \ 0.001) than those without shock. Survivors had a
higher MAP and MPP but a lower central venous pres-
sure, mean pulmonary artery blood pressure, SOFA score,
SAPS II, APACHE II, and longer hospital length of stay
(Table 2). Moreover, they required catecholamines and
renal replacement therapy less often than nonsurvivors.
Association of different ABP levels and 28-day-
mortality
There was a significant association between the hourly
blood pressure time integral of SAP, MAP, as well as
MPP and 28-day-mortality (Fig. 1). The areas under the
ROC curve were largest for the hourly time integrals of
ABP drops below MAP 60 mmHg and MPP 45 mmHg.
No significant association between the hourly time inte-
grals of ABP drops below certain SAP levels and 28-day-
mortality could be detected (Table 3). While the areas
under the ROC curve were not different between the
hourly time integrals of ABP drops below single MPP
levels, the area under the ROC curve of the hourly time
integral of ABP drops below MAP 60 mmHg was higher
than that of MAP 55 (P = 0.01), 50 (P = 0.002) and
45 mmHg (P \ 0.001). There were no differences
between the areas under the ROC curves of the hourly
time integrals of ABP drops below MAP 60 mmHg and
MAP levels C 65 mmHg.
Patients with one or more hypotensive episodes
(MAP \ 60 mmHg for C2 min) had a higher 28-day-
mortality than patients without such a hypotensive epi-
sode during the observation period (29.8 vs. 12.5%; OR,
2.96; CI 95%, 1.06–10.36; P = 0.04). There was a linear
association between the time below MAP 60 mmHg and
28-day-mortality (Fig. 2). Survivors had a shorter time
below MAP 60 mmHg than nonsurvivors (Table 4).
When including only patients who required catechola-
mines into the binary logistic regression analysis, the
areas under the ROC curve were similarly largest for the
hourly time integrals of ABP drops below MAP 60 and
MPP 45 mmHg.
Association with organ function (Table 5)
The hourly blood pressure time integrals of measured
SAP, MAP and MPP were associated with maximum
SOFA score, arterial lactate concentrations, need for renal
replacement therapy, maximal serum creatinine concen-
trations, and hourly urine output, but not with liver
function parameters. Inclusion of covariates (age, hourly
cardiac index time integral, chronic arterial hypertension,
catecholamines, analgosedative drugs) did not influence
the association between ABP and renal function. The
areas under the ROC curve to predict the need for renal
replacement therapy were highest for the hourly time
integrals of ABP drops below MAP 75 mmHg (AUC
ROC, 0.724; Sensitivity, 2.1%; Specificity, 97.8%; Posi-
tive Predictive Value, 16.7%; Negative Predictive Value,
82.7%; P \ 0.001) and MPP 60 mmHg (AUC ROC,
0.721; Sensitivity, 11.4%; Specificity, 97.8%; Positive
Predictive Value, 55.6%; Negative Predictive Value,
82%; P \ 0.001).
Discussion
In this study, we analyzed ABP in the first 24 h after ICU
admission because of sepsis or septic shock since early
cardiovascular failure is likely to influence subsequent
organ function and outcome [22]. Because the first 24 h in
Table 1 Characteristics of the study population
n 274
Age (years) 61 ± 16
Male sex, n (%) 170 (62)
Premorbidites, n (%)
cAHT 104 (38)
CHD 62 (22.6)
CHF 41 (15)
COPD 48 (17.5)
CRI 37 (13.5)
CLD 26 (9.5)
Neoplasm 50 (18.2)
Origin of ICU admission, n (%)
Ward 92 (33.6)
Operation room 82 (30)
Other hospital 75 (27.4)
Emergency department 25 (9.1)
Source of infection, n (%)
Lungs 111 (40.5)
Urinary tract 14 (5.1)
Skin/soft tissue 27 (9.9)
Liver/abdomen 73 (26.7)
Catheter/device 9 (3.3)
CNS 15 (5.5)
Endocarditis 13 (4.8)
Bone 2 (0.7)
Other/unknown 10 (3.7)
Sepsis, n (%) 126 (46)
Septic shock, n (%) 148 (54)
SOFA (points) 10.6 ± 5.1
SAPS II (points) 51.5 ± 19.9
APACHE II (points) 27.3 ± 7.8
ICU LOS (days) 6.8 ± 9
Hospital LOS (days) 23.6 ± 21.5
ICU mortality, n (%) 53 (19.3)
28-day-mortality, n (%) 76 (27.7)
Data are given as mean values ± SD, if not indicated otherwise
cAHT chronic arterial hypertension, CHD coronary heart disease,
CHF congestive heart failure, COPD chronic obstructive pulmon-
ary disease, CRI chronic renal insufficiency, CLD chronic liver
disease, CNS central nervous system, SOFA sequential organ fail-
ure assessment, SAPS simplified acute physiology score, APACHE
acute physiologic and chronic health evaluation, ICU intensive care
unit, LOS length of stay
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Fig. 1 Results are based on a binary logistic regression model
which was adjusted for disease severity as assessed by the
Simplified Acute Physiology Score II (excl. SAP) during the first
24 h after intensive care unit admission. The AUC ROC (calculated
from the results of the binary logistic regression analysis)
represents the area under the receiver operating characteristic
curve of the hourly blood pressure time integral of the respective
arterial blood pressures. SAP hourly blood pressure time integral of
systolic arterial blood pressure, MAP hourly blood pressure time
integral of mean arterial blood pressure, MPP hourly blood
pressure time integral of mean perfusion pressure
Table 3 Association between different arterial blood pressure levels and 28-day-mortality adjusted for disease severity
na Mean ± SDb AUC ROC Sens (%) Spec (%) PPV (%) NPV (%) P value
SAP
HTI of ABP drops \ 95 mmHg SAP 246 308 ± 604 0.743 93.4 29 77.4 62.9 0.06
HTI of ABP drops \ 90 mmHg SAP 235 212 ± 542 0.737 94.4 26.3 77 64.5 0.12
HTI of ABP drops \ 85 mmHg SAP 217 143 ± 489 0.734 93.4 25 76 59.4 0.22
HTI of ABP drops \ 80 mmHg SAP 189 96 ± 444 0.731 94.4 26.3 77 64.5 0.4
HTI of ABP drops \ 75 mmHg SAP 159 67 ± 406 0.731 94.4 26.3 77 64.5 0.63
HTI of ABP drops \ 70 mmHg SAP 124 50 ± 373 0.731 94.4 26.3 77 64.5 0.84
HTI of ABP drops \ 65 mmHg SAP 77 38 ± 343 0.731 94.4 26.3 77 64.5 0.99
MAP
HTI of ABP drops \ 75 mmHg MAP 261 475 ± 388 0.775 93.4 42.1 80.7 71.1 \0.001**
HTI of ABP drops \ 70 mmHg MAP 252 297 ± 303 0.777 94.9 40.8 80.6 75.6 \0.001**
HTI of ABP drops \ 65 mmHg MAP 245 162 ± 217 0.778 95.9 39.5 80.4 79 \0.001**
HTI of ABP drops \ 60 mmHg MAP 220 74 ± 141 0.779 95.4 39.5 80.3 76.9 \0.001**
HTI of ABP drops \ 55 mmHg MAP 177 30 ± 86 0.764 94.9 32.9 78.6 71.4 0.001**
HTI of ABP drops \ 50 mmHg MAP 135 11 ± 49 0.757 94.9 26.3 77 66.7 0.02
HTI of ABP drops \ 45 mmHg MAP 85 5 ± 28 0.751 94.4 29 77.5 66.7 0.05
HTI of ABP drops \ targeted MAP 159 56 ± 113 0.769 95.4 37.3 78.1 80 0.001*
MPP
HTI of ABP drops \ 60 mmHg MPP 210 398 ± 432 0.788 92.4 42.9 74.4 71.4 \0.001**
HTI of ABP drops \ 55 mmHg MPP 200 252 ± 343 0.791 92.4 41.4 78 70.7 \0.001**
HTI of ABP drops \ 50 mmHg MPP 177 147 ± 254 0.793 92.4 40 77.5 70 \0.001**
HTI of ABP drops \ 45 mmHg MPP 159 77 ± 175 0.797 92.4 40 77.5 70 \0.001**
HTI of ABP drops \ 40 mmHg MPP 128 38 ± 111 0.793 93 38.6 77.3 71.1 0.001**
HTI of ABP drops \ 35 mmHg MPP 90 17 ± 63 0.792 93.6 38.6 77.4 73 0.01
HTI of ABP drops \ 30 mmHg MPP 60 7 ± 31 0.782 90.5 37.1 76.3 63.4 0.02
The hourly time integral (HTI) of arterial blood pressure (ABP)
drops below certain pressure limits represents the duration and
extent of blood pressure drops below the respective arterial blood
pressure level per hour. Results are based on a binary logistic
regression model which was adjusted for disease severity as assesed
by the Simplified Acute Physiology Score II count (excl. SAP)
during the first 24 h after intensive care unit admission. The tar-
geted MAP was available in 240 study patients
SAP systolic arterial blood pressure, AUC ROC area under the
receiver operating characteristic curve, Sens sensitivity, Spec
specifity, PPV positive predictive value, NPV negative predictive
value, MAP mean arterial blood pressure, MPP mean perfusion
pressure
** Significant association between ABP target and mortality
a Number of patients who experienced an arterial blood pressure
drop below the given limit
b Mean values ± SD refer to the HTI of ABP drops below certain
arterial blood pressure levels and are given in mmHg min/h
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the ICU do not necessarily represent the start of the dis-
ease process, the lead-time bias is difficult to quantify and
contributes to the presence and successive development of
hemodynamic and remote organ dysfunction. Neverthe-
less, the association between ABP during the early phase
of sepsis and septic shock and outcome in the present
study has also been reported by others [2, 3, 13, 23]. In
this study, ABP was associated with 28-day-mortality
even when corrected for the impact of disease severity.
Currently, a MAP of 65–90 mmHg is a widely
accepted and recommended blood pressure range for
critically ill sepsis patients [7–9, 24]. In our study popu-
lation, there was no difference in the risk of death at
28 days between ABP drops below MAP of 60, 65, 70
and 75 mmHg. When analysing the hourly time integral
of ABP drops below a MAP of 55 mmHg, a significant
decrease in the area under the ROC curve was observed.
This suggests that a MAP of 60 mmHg during the first
24 h of ICU therapy represents a critical level in our study
population. Since the ABP target determines the defini-
tion of septic shock, we chose to avoid this confounding
factor and included all sepsis patients. Had only septic
shock patients (e.g. patients with vasopressors, according
to the targets set by the clinician) been included, critical
ABP levels may have been different.
Furthermore, it needs to be considered that we ana-
lyzed the hourly time integral of ABP drops below certain
ABP levels. This method pools hourly ABP data but does
not account for temporary variations and hence cannot be
considered as the total amount of hypotension exposure
over 24 h. Despite of including 274 patients into this
analysis, the statistical power may still be too low to
reliably exclude a mortality difference between a MAP of
60 mmHg and higher MAP levels. Since our analysis
primarily evaluated ABP levels and no specific treatment
goals, we can neither determine whether the critical MAP
level of 60 mmHg may equally represent the optimum
therapeutic goal. In order to evaluate the influence of a
MAP goal of C60 mmHg on mortality in sepsis patients,
future prospective trials are needed. Such studies could
also provide information if a safety margin (e.g. 5 mmHg)
above the critical MAP level of 60 mmHg may be useful
to avoid detrimental hypotensive episodes or would
increase catecholamine requirements without exerting
beneficial effects on tissue perfusion and mortality.
In a recent study, Varpula et al. [13], using ROC
analysis, identified a MAP of 65 mmHg as the best limit
to discriminate surviving and nonsurviving septic shock
patients. This difference to our study may be explained by
the lack of correction for disease severity. Whereas the
APACHE II Score count was higher in our than in
Varpula’s patient population, the degree of multiple organ
dysfunction appears comparable when considering SOFA
score counts of the two study groups. When a simple,
unadjusted ROC analysis is applied to our data, a MAP of
65 mmHg similarly shows the largest area under the ROC
curve for 28-day-mortality (Electronic Repository). MAP
was also the hemodynamic parameter which was most
significantly associated with 28-day-mortality in a mul-
tiple logistic regression model (Electronic Repository).
MPP also showed a significant association with mor-
tality. According to a well-established physiologic, but
clinically rarely applied concept, organ blood flow is
determined by the pressure gradient (arterial–venous
pressure) across the organ vasculature divided by the total
resistance of the organ vascular bed [25]. Despite the
physiologic limitations of central venous pressure to
reflect organ specific venous pressure, MPP includes an
estimation of perfusion pressure. It is therefore conceiv-
able that it should correlate equally well or better with
mortality and renal function than SAP or MAP alone.
However, the current value of MPP as a therapeutic target
is unproven and needs to be addressed in clinical trials.
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Fig. 2 The histogram shows the association between 28-day-
mortality and the total time spent below a MAP level of 60 mmHg
during the first 24 h after intensive care unit admission in all study
patients. The number of patients in each time range was 0–4 h,
n = 180; 4–8 h, n = 37; 8–12 h, n = 20; 12–16 h, n = 20; 16–20 h,
n = 10; and 20–24 h, n = 7. MAP mean arterial blood pressure.
*Significant difference between survivors and nonsurvivors
Table 4 Hourly and daily time in minutes spent below a mean arterial blood pressure of 60 mmHg in survivors and nonsurvivors
Survivors Nonsurvivors
Mean ± SD CI 95% Mean ± SD CI 95% P value
MAP \60 mmHg/h (min) 9 ± 13 7–11 22 ± 20 17–26 \0.001*
MAP \60 mmHg/day (min) 195 ± 272 157–233 455 ± 433 356–554 \0.001*
MAP mean arterial blood pressure
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The observation that ABP during the first 24 h was
associated with SOFA score and arterial lactate concen-
trations supports and may partly explain the association
between ABP and mortality. However, given the infusion
of epinephrine in *15% of patients, arterial lactate levels
may not have reflected tissue hypoperfusion in all patients
[26]. Together with the fact that several further therapeutic
steps influence 28-day-mortality in sepsis patients, this may
explain why only low r2 values were detected for the
association between ABP and organ functions. Out of all
organs, the kidney is known to have the highest autoreg-
ulation threshold [25, 27, 28]. Accordingly, the MAP and
MPP levels to discriminate study patients who did or did
not require renal replacement therapy were 75 and
60 mmHg, respectively. Since these were the highest MAP
and MPP levels tested, it cannot be excluded that the
critical ABP levels for renal function are even higher.
While a small-size prospective study found no influence of
increasing MAP from 65 to 85 mmHg with norepinephrine
on renal function in septic shock patients [12], Deruddre
et al. [29] suggested that Doppler ultrasonography and
resistive index measurements could help determine the
optimum MAP for renal blood flow in septic shock.
When interpreting the results of this study important
limitations need to be considered. A major limitation is
the retrospective and uncontrolled design. Since a
guideline instead of a strict protocol was used, some
variations in therapeutic practice were certainly present.
Despite automated capture of frequently sampled filtered
data, missing data due to interventions and diagnostic
procedures cannot be avoided. Considering the amount of
data available for analysis and the use of mean values
over 24 h, this is likely to have only a minor influence on
the association between ABP and mortality. Because
only patients monitored with an arterial line were inclu-
ded, a selection bias by excluding less severe sepsis
patients who could be managed with non-invasive ABP
measurements may have occurred.
In conclusion, a MAP level C 60 mmHg may be as
safe as higher MAP levels during the first 24 h of ICU
therapy in septic patients. A higher MAP may be required
to maintain kidney function. Future randomized clinical
trials are necessary to evaluate the MAP targets in sepsis.
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